# BAYER PHARMA, AG – FDA Inspection, Jan 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/5e47f2e1-951b-482a-ad43-bb89fe81b130
Source feed: FDA_Inspections

> FDA inspection 1001127 of BAYER PHARMA, AG, January 24, 2017. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001127
- Company Name: BAYER PHARMA, AG
- Inspection Date: 2017-01-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1282736 - 2024-06-06](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/1d238dca-b4e7-4c8f-8c8c-40de3cf1da86)
- FDA Inspection 1239178 - 2021-08-27
- [FDA Inspection 1102816 - 2019-09-24](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/f4d6e717-a64d-42ca-931d-40fe4ad01598)
- [FDA Inspection 1023408 - 2017-07-03](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/4cad4b59-7cd0-472e-b6f8-749df0c15721)
- [FDA Inspection 889209 - 2014-05-13](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/62dcd89d-3755-4ff0-bfd0-1cd68e1ec209)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nadeem-i-chaudhry/7d867939-2dc6-4503-b9b9-6f26b16c347e)

Company: https://www.keypedia.com/companies/bayer-pharma-ag/28300a22-c506-4b1a-9052-6fc4e7170384

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c